ClinicalTrials.gg
CompletedNCT07607886PFN-RARUpdated Oct 15, 2026

Inflammatory Indices, Early Mortality, and ICU Stay in Geriatric PFN Patients

An observational study in Intertrochanteric Femur Fracture, Hip Fracture Surgeries and Geriatric Anesthesia, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Saglik Bilimleri Universitesi · Observational

How we know

Updated Oct 15, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
233
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 78 studies in Hip Fractures with a site in Turkey — 14 open to participants now, 18 under way, none of them phase 3. Hip Fractures · Turkey.

Enrollment
3rd of 40
233 · median 98
Started
2021
with 6 others
Observational
40 of 78
9 open now
Registered
72nd of 78
by date

Among the 78 studies in Hip Fractures with a site in Turkey, this one is the 3rd largest by enrollment of the 40 observational ones that give a count, is one of 7 that started in 2021, is one of 40 observational ones, and was the 72nd registered.

Hip Fractures

843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.

Browse Hip Fractures studies →

Open to participants now

14 of the 78 studies in Hip Fractures with a site in Turkey are open now. Recruiting first, the newest first:

9 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Hip Fractures with a site in Turkey, or all of them as a file.
02

Study summary

This retrospective observational cohort study aims to evaluate the association between preoperative and postoperative inflammatory indices and early postoperative outcomes in geriatric patients undergoing proximal femoral nailing (PFN) for intertrochanteric femur fractures. The primary outcome of the study is 30-day mortality, while the secondary outcome is intensive care unit (ICU) length of stay. Various inflammatory biomarkers derived from routine laboratory parameters, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), immune-inflammatory prognostic index (IPI), aggregate index of systemic inflammation (AIS), and RDW-to-albumin ratio (RAR), will be analyzed to investigate their prognostic value in the acute postoperative period. The study seeks to identify simple and readily accessible biomarkers that may contribute to early risk stratification and perioperative management in elderly hip fracture patients.

Read the detailed description

Hip fractures are associated with substantial morbidity and mortality in the geriatric population. Intertrochanteric femur fractures, in particular, frequently require surgical stabilization with proximal femoral nailing (PFN). Despite advances in perioperative care, early postoperative mortality rates and intensive care utilization remain high in elderly patients undergoing PFN surgery. Identifying reliable biomarkers that reflect the acute systemic inflammatory response to surgical trauma may improve perioperative risk stratification and postoperative management.

In recent years, several hematologic inflammatory indices derived from routine laboratory parameters have emerged as potential prognostic markers in different clinical settings. These include neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), aggregate index of systemic inflammation (AIS), immune-inflammatory prognostic index (IPI), and red cell distribution width-to-albumin ratio (RAR). However, data regarding the prognostic significance of these inflammatory indices in geriatric orthopedic trauma patients remain limited.

This retrospective observational cohort study evaluates the association between preoperative and postoperative inflammatory indices and early postoperative outcomes in geriatric patients undergoing PFN surgery for intertrochanteric femur fractures. Electronic medical records of eligible patients aged 65 years and older will be reviewed retrospectively. Demographic characteristics, comorbidities, perioperative laboratory findings, inflammatory indices, 30-day mortality, and intensive care unit (ICU) length of stay will be analyzed.

The primary outcome of the study is 30-day mortality. The secondary outcome is ICU length of stay. The study aims to determine whether inflammatory indices, particularly RDW-to-albumin ratio (RAR), are independently associated with early mortality and prolonged ICU stay in the acute postoperative period. The findings may contribute to the identification of simple and cost-effective biomarkers for early risk assessment in geriatric hip fracture patients.

03

Conditions studied

  • Intertrochanteric Femur Fracture
  • Hip Fracture Surgeries
  • Geriatric Anesthesia

Browse trials for

Keywords

  • Proximal Femoral Nailing
  • Inflammatory Indices
  • RDW-to-Albumin Ratio
  • Early Mortality
  • Intensive Care Unit
  • Geriatric Patients
  • Hip Fracture Surgery
  • RAR
  • PFN
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Geriatric patients aged 65 years and older who underwent proximal femoral nailing (PFN) surgery for intertrochanteric femur fractures at a tertiary referral center were retrospectively evaluated. The study population consisted of patients with available perioperative laboratory data, 30-day mortality information, and intensive care unit follow-up records.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 65 years and older
  • Diagnosis of intertrochanteric femur fracture
  • Undergoing proximal femoral nailing (PFN) surgery
  • Availability of preoperative laboratory data
  • Availability of early postoperative laboratory measurements
  • Availability of 30-day mortality data
  • Availability of intensive care unit admission and ICU length of stay data
  • Complete electronic medical records

Exclusion criteria

Exclusion Criteria:

  • Patients with missing clinical or laboratory data
  • Pathological fractures
  • Multiple trauma patients
  • Revision surgeries
  • Presence of active infection or sepsis before surgery
  • Hematologic diseases that could affect inflammatory indices
  • Unavailable 30-day mortality or ICU data
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
233 participants (actual)
Patient registry
No

Groups and cohorts

  • Geriatric PFN Cohort

    Geriatric patients aged 65 years and older who underwent proximal femoral nailing (PFN) surgery for intertrochanteric femur fractures and were retrospectively evaluated for inflammatory indices, 30-day mortality, and intensive care unit length of stay.

06

What researchers measure

Primary outcomes

  1. 30-Day Mortality

    Evaluation of all-cause mortality occurring within the first 30 postoperative days in geriatric patients undergoing proximal femoral nailing surgery.

    Time frame: Within 30 days after surgery

Secondary outcomes

  1. Intensive Care Unit Length of Stay

    ICU stay duration in days

    Time frame: 30 days

07

Study locations

1 site
  • University of Health Sciences Gazi Yaşargil Training and Research Hospital
    Diyarbakır, Diyarbakır, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jan 2021 to primary completion in Dec 2025, 59 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Jun 2026 → Dec 2025 and completion Jun 2026 → Dec 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 12, 2026
First posted
May 26, 2026
StartActual
Jan 1, 2021
Primary completionActual
Dec 1, 2025was Jun 2026
CompletionActual
Dec 30, 2025was Jun 2026
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 15, 2026
Primary completion
Jun 15, 2026→Dec 1, 2025 (actual)
Oct 15, 2026
Study completion
Jun 30, 2026→Dec 30, 2025 (actual)
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Active, not recruiting→Completed
    Primary completion Jun 15, 2026→Dec 1, 2025 (now actual)
    Study completion Jun 30, 2026→Dec 30, 2025 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07607886
Responsible party
Selen Topalel (Anesthesiologist, Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital) — Principal investigator
First posted
May 26, 2026
Start date
Jan 1, 2021
Primary completion
Dec 1, 2025
Completion
Dec 30, 2025
Last update
Oct 15, 2026

Study contacts

selen topalel, MD
principal investigator · Department of Anesthesiology and Reanimation, Gazi Yaşargil Training and Research Hospital, University of Health Sciences, Diyarbakır, Türkiye

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion